Kulanthaivel P, Hallock YF, Boros C, Hamilton SM, Janzen WP, Ballas LM, Loomis CR, Jiang JB, Katz B (1993). "Balanol: A novel and potent inhibitor of protein kinase C from the fungus Verticillium balanoides". J. Am. Chem. Soc. 115 (14): 6452–6453. Bibcode:1993JAChS.115.6452K. doi:10.1021/ja00067a087.
Pande V, Ramos MJ, Gago F (August 2008). "The Protein kinase inhibitor balanol: structure-activity relationships and structure-based computational studies". Anti-Cancer Agents in Medicinal Chemistry. 8 (6): 638–45. doi:10.2174/187152008785133056. PMID18690827.
Gassel M, Breitenlechner CB, Rüger P, Jucknischke U, Schneider T, Huber R, et al. (June 2003). "Mutants of protein kinase A that mimic the ATP-binding site of protein kinase B (AKT)". Journal of Molecular Biology. 329 (5): 1021–34. doi:10.1016/S0022-2836(03)00518-7. PMID12798691.
Narayana N, Diller TC, Koide K, Bunnage ME, Nicolaou KC, Brunton LL, et al. (February 1999). "Crystal structure of the potent natural product inhibitor balanol in complex with the catalytic subunit of cAMP-dependent protein kinase". Biochemistry. 38 (8): 2367–76. doi:10.1021/bi9820659. PMID10029530.
Setyawan J, Koide K, Diller TC, Bunnage ME, Taylor SS, Nicolaou KC, Brunton LL (August 1999). "Inhibition of protein kinases by balanol: specificity within the serine/threonine protein kinase subfamily". Molecular Pharmacology. 56 (2): 370–6. doi:10.1124/mol.56.2.370. PMID10419556.
Gustafsson AB, Brunton LL (August 1999). "Differential and selective inhibition of protein kinase A and protein kinase C in intact cells by balanol congeners". Molecular Pharmacology. 56 (2): 377–82. doi:10.1124/mol.56.2.377. PMID10419557.
Kulanthaivel P, Hallock YF, Boros C, Hamilton SM, Janzen WP, Ballas LM, Loomis CR, Jiang JB, Katz B (1993). "Balanol: A novel and potent inhibitor of protein kinase C from the fungus Verticillium balanoides". J. Am. Chem. Soc. 115 (14): 6452–6453. Bibcode:1993JAChS.115.6452K. doi:10.1021/ja00067a087.
Pande V, Ramos MJ, Gago F (August 2008). "The Protein kinase inhibitor balanol: structure-activity relationships and structure-based computational studies". Anti-Cancer Agents in Medicinal Chemistry. 8 (6): 638–45. doi:10.2174/187152008785133056. PMID18690827.
Gassel M, Breitenlechner CB, Rüger P, Jucknischke U, Schneider T, Huber R, et al. (June 2003). "Mutants of protein kinase A that mimic the ATP-binding site of protein kinase B (AKT)". Journal of Molecular Biology. 329 (5): 1021–34. doi:10.1016/S0022-2836(03)00518-7. PMID12798691.
Narayana N, Diller TC, Koide K, Bunnage ME, Nicolaou KC, Brunton LL, et al. (February 1999). "Crystal structure of the potent natural product inhibitor balanol in complex with the catalytic subunit of cAMP-dependent protein kinase". Biochemistry. 38 (8): 2367–76. doi:10.1021/bi9820659. PMID10029530.
Setyawan J, Koide K, Diller TC, Bunnage ME, Taylor SS, Nicolaou KC, Brunton LL (August 1999). "Inhibition of protein kinases by balanol: specificity within the serine/threonine protein kinase subfamily". Molecular Pharmacology. 56 (2): 370–6. doi:10.1124/mol.56.2.370. PMID10419556.
Gustafsson AB, Brunton LL (August 1999). "Differential and selective inhibition of protein kinase A and protein kinase C in intact cells by balanol congeners". Molecular Pharmacology. 56 (2): 377–82. doi:10.1124/mol.56.2.377. PMID10419557.
